Skip to main content

Clinical Trials › NCT05811416

Active, Not Recruiting

A Study to Describe the Persistence With Ozanimod Treatment in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants

Sponsored by Bristol-Myers Squibb

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov
200
Target enrollment
Jun 2023
Start date
Nov 2026
Expected completion

Conditions studied

Relapsing-remitting Multiple Sclerosis (RRMS)

Trial locations

U.S. site locations haven't been posted yet for this trial. Check ClinicalTrials.gov for the latest contact and location info.

The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play